Compare · CI vs MDXH
CI vs MDXH
Side-by-side comparison of The Cigna Group (CI) and MDxHealth SA (MDXH): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CI and MDXH operate in Medical Specialities (Health Care), so they compete in similar markets.
- CI is the larger of the two at $76.61B, about 2731.7x MDXH ($28.0M).
- Over the past year, CI is down 6.3% and MDXH is down 73.6% - CI leads by 67.3 points.
- MDXH has been more active in the news (10 items in the past 4 weeks vs 4 for CI).
- CI has more recent analyst coverage (25 ratings vs 5 for MDXH).
- Company
- The Cigna Group
- MDxHealth SA
- Price
- $291.57+0.72%
- $0.58+5.32%
- Market cap
- $76.61B
- $28.0M
- 1M return
- +1.20%
- -71.14%
- 1Y return
- -6.33%
- -73.64%
- Industry
- Medical Specialities
- Medical Specialities
- Exchange
- NYSE
- NASDAQ
- IPO
- 2021
- News (4w)
- 4
- 10
- Recent ratings
- 25
- 5
The Cigna Group
Cigna Corporation provides insurance and related products and services in the United States. Its Evernorth segment provides a range of coordinated and point solution health services, including pharmacy, benefits management, care, and intelligence solutions to health plans, employers, government organizations, and health care providers. The company's U.S. Medical segment offers commercial products and services, including medical, pharmacy, behavioral health, dental, vision, health advocacy programs, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as Medicaid plans; and individual health insurance plans to on and off the public exchanges. Its International Markets segment offers health coverage, hospitalization, dental, critical illness, personal accident, term life, medical cost containment, and variable universal life products, as well as health care benefits to mobile employees of multinational organizations. The company distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.
MDxHealth SA
MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, the Netherlands, Belgium, Spain, Poland, Italy, rest of European Union, and internationally. Its novel prostate cancer genomic testing solutions are SelectMDx, a non-invasive urine test; and ConfirmMDx, an epigenetic test, which provide physicians with a clinical pathway to identify clinically prostate cancer while minimizing the use of invasive procedures that are prone to complications. The company was formerly known as OncoMethylome Sciences SA and changed its name to MDxHealth SA in October 2010. MDxHealth SA was incorporated in 2003 and is headquartered in Herstal, Belgium.
Latest CI
- EVP, Global CIO Koka Durga Prasad covered exercise/tax liability with 729 shares, decreasing direct ownership by 10% to 6,552 units (SEC Form 4) (withholding tax)
- SEC Form 4 filed by Director Kurian George
- The Cigna Group downgraded by Barclays with a new price target
- The Cigna Group downgraded by Deutsche Bank with a new price target
- Chairman & CEO Cordani David exercised 212,543 shares at a strike of $170.34 and sold $59,114,186 worth of shares (201,878 units at $292.82) as part of a pre-agreed trading plan, increasing direct ownership by 23% to 57,766 units (SEC Form 4)
- The Cigna Group filed SEC Form 8-K: Regulation FD Disclosure
- The Cigna Group Announces Appearance at the BofA Securities 2026 Health Care Conference
- Kayne Anderson Energy Infrastructure Fund Announces Appointment of Michael J. Hennigan as New Independent Director
- SEC Form 144 filed by The Cigna Group
- SEC Form 10-Q filed by The Cigna Group
Latest MDXH
- SEC Form 4 filed by Officer Sollee Joseph
- SEC Form 4 filed by Director Hardison Don M
- SEC Form 4 filed by Chief Executive Officer Mcgarrity Michael
- SEC Form 4 filed by VP, Finance and Accounting Oconnell Brendan
- SEC Form 4 filed by Director Hoffman Koen
- SEC Form 4 filed by Chief Commercial Officer Bellano John
- SEC Form 4 filed by Director Siegel Sanford Jay
- SEC Form 4 filed by Director Windels Hilde
- SEC Form 4 filed by Director Holder Michael
- SEC Form 3 filed by new insider Oconnell Brendan